Literature DB >> 1408313

The role of ischaemia in the analgesia which follows Bier's block technique.

Roberto Casale1, Chris Glynn, Michelangelo Buonocore.   

Abstract

The effect of 30-min tourniquet ischaemia (Bier's block) on the antidromic homolateral left median nerve sensory potential (SP) and on the bilateral sympathetic skin response (SSR) was studied in 6 healthy volunteers. The SSR was provoked both acoustically and by electrical stimulation of the median nerve; the latter stimulus was also used to provoke the SP. After 28 min of tourniquet ischaemia, the electrical stimulus failed to provoke the SP and bilateral SSR, indicating blockade of the afferent limb of the reflex. The acoustic SSR was unaffected by ischaemia, and thus the efferent limb of the SSR was not blocked, indicating that ischaemia does not affect the post-ganglionic efferent C fibres. These findings confirm that 30 min of ischaemia blocks A beta afferent fibres but does not block efferent C fibres. Thus the analgesia following Bier's block alone, in some patients with sympathetically maintained pain, most likely results from the ischaemic blockade of sensory A beta fibres, confirmed both acoustically and by electrical stimulation of the median nerve.

Entities:  

Mesh:

Year:  1992        PMID: 1408313     DOI: 10.1016/0304-3959(92)90158-8

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  3 in total

Review 1.  How do drugs relieve neurogenic pain?

Authors:  R Karlsten; T Gordh
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

2.  A sequential allocation study to determine the ED50 of Dexmedetomidine as an adjuvant to lidocaine intravenous regional anesthesia.

Authors:  Cynthia Karam; Sadek Al Assadi; Ghassan Kanazi; Carine Zeeni
Journal:  BMC Anesthesiol       Date:  2022-05-27       Impact factor: 2.376

3.  Effect of guanethidine on the natural history of post-traumatic algodystrophy.

Authors:  J Field; R M Atkins
Journal:  Ann Rheum Dis       Date:  1993-06       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.